Established in 1972, this Manufacturer is a trusted CTD dossier owner and manufacturer based in Taichung City, Taiwan, with over 50 years of experience. As a GMP manufacturer, it operates state-of-the-art production facilities fully compliant with strict Good Manufacturing Practices (GMP) standards. The Manufacturer offers a diverse product portfolio, including prescription medicines, over-the-counter drugs, and health supplements, focusing on therapeutic areas such as cardiovascular, gastrointestinal, and metabolic health. As a CTD dossier owner and manufacturer, it ensures full compliance with international regulatory requirements. Dedicated to excellence, this GMP manufacturer continues to expand its presence in regulated markets worldwide.

Established in 1963, this Manufacturer is a CTD dossier owner and manufacturer based in Tainan City, Taiwan. With a workforce of approximately 653 employees, it operates GMP-certified facilities producing a diverse range of products, including tablets, capsules, oral liquids, external liquids, and health foods. As a GMP manufacturer, it holds certifications such as cGMP, PIC/S GMP, ISO 14001, and TIPS (Taiwan Intellectual Property Scheme), ensuring adherence to international quality standards. The Manufacturer's products are distributed across various countries and regions worldwide. Its commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

​Established in 1961, this Manufacturer is a CTD dossier owner and manufacturer based in Taichung City, Taiwan. It operates GMP-certified facilities producing a diverse range of products, including tablets, capsules, oral liquids, external liquids, and health foods. As a GMP manufacturer, it ensures adherence to international quality standards. The Manufacturer's products are distributed across various countries and regions worldwide. Its commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​